ID: ALA433886

Max Phase: Preclinical

Molecular Formula: C25H25ClN2O3

Molecular Weight: 436.94

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1c(COc2ccc(Cl)cc2)oc2cccc(OCCCNCc3cccnc3)c12

Standard InChI:  InChI=1S/C25H25ClN2O3/c1-18-24(17-30-21-10-8-20(26)9-11-21)31-23-7-2-6-22(25(18)23)29-14-4-13-28-16-19-5-3-12-27-15-19/h2-3,5-12,15,28H,4,13-14,16-17H2,1H3

Standard InChI Key:  YXBVEDYIACFQGK-UHFFFAOYSA-N

Associated Targets(Human)

Peptide N-myristoyltransferase 241 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Candida albicans 78123 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 436.94Molecular Weight (Monoisotopic): 436.1554AlogP: 5.93#Rotatable Bonds: 10
Polar Surface Area: 56.52Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.80CX LogP: 4.78CX LogD: 3.37
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.31Np Likeness Score: -0.85

References

1. Ebiike H, Masubuchi M, Liu P, Kawasaki K, Morikami K, Sogabe S, Hayase M, Fujii T, Sakata K, Shindoh H, Shiratori Y, Aoki Y, Ohtsuka T, Shimma N..  (2002)  Design and synthesis of novel benzofurans as a new class of antifungal agents targeting fungal N-myristoyltransferase. Part 2.,  12  (4): [PMID:11844682] [10.1016/s0960-894x(01)00808-3]

Source